Thermo Fisher Scientific (TMO)
$365.89 6.12 (1.70%)
16:51 EDT TMO Stock Quote Delayed 30 Minutes
Previous Close $359.77
Market Cap 147.21B
PE Ratio 64.99
Volume (Avg. Vol.) 1.13M
Day's Range 362.00 - 369.82
52-Week Range 250.21 - 363.97
Dividend & Yield 0.66 (0.18%)
TMO Stock Predictions, Articles, and Thermo Fisher Scientific News
- From InvestorPlace
- From the Web
By Ian Cooper
The global nanotechnology market could exceed $125 billion by 2024, as it continues to impact technology, energy, defense, and even food.
Friday's big stock charts feature three large-cap names that have found a bottom — and which could keep rallying, particularly with outside help.
Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.
We saw equities fall in the stock market today, despite the Federal Reserve stepping up with an emergency 50-basis-points rate cut.
Politicians have investors in healthcare stocks nervous as the 2020 election nears. Here's a guide to which firms are good choices and which you should avoid.
Nanotech stocks cover a broad range of industries as their underlying innovation impacts all corners of business and society.
One of the best mutual funds last year was the T. Rowe Price Health Sciences Fund. Here are 7 healthcare stocks to buy from its holdings.
Thanks to evolving economic conditions, several publicly traded firms are turning to stock buyback programs to make efficient use of capital.
Stock charts of Thermo Fisher Scientific, Intuit Intercontinental Exchange have all earned a closer inspection here.
Looking for some stocks to buy that you don't have to babysit? These names are in a bullish groove that looks secure enough.
These ten stocks are currently the most expensive stocks trading on the S&P 500 -- so buyer beware.
Thermo Fisher Scientific Inc (NYSE:TMO) is ranked as a Buy using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. TMO has maintained this ranking for 2 months.
Thermo Fisher Scientific Inc (NYSE:TMO) is ranked as a Buy using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.
The current recommendation of Buy for Thermo Fisher Scientific Inc (NYSE:TMO) is derived using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.
Thermo Fisher Scientific Inc (NYSE:TMO) ranks in the top 10% of its industry group, Life Sciences Tools & Services, and in the top 10% of its sector group, Health Care, with a market value of $74.7 billion. From an investment attractiveness prospective, TMO is ranked in the top half of the sector with a ranking of 311 among the 782 companies in the sector; the ranking for TMO by Portfolio Grader places it 20 among the 33 companies in this industry group, giving it a lower than average position and number 1,957 in the 5000 company Portfolio Grader company universe.
Thermo Fisher Scientific Inc (NYSE:TMO) is one of the 785 companies in the GICS Health Care sector, and a constituent of the 33 company Life Sciences Tools & Services GICS industry group within this sector. The market value of TMO is $77.7 billion which falls in the top 10% of its industry group. The ranking for TMO by Portfolio Grader places it 17 among the 33 companies in this industry group, giving it a below-average spot; in the top half of the sector with a ranking of 234 among the 785 companies in the sector, and number 1,518 in the nearly 5,000 company Portfolio Grader universe.
Portfolio Grader currently ranks Thermo Fisher Scientific Inc (NYSE:TMO) a Buy. The methodology for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. TMO has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.
Navellier RatingsPowered by Portfolio Grader